Skip to content

Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors

Development and Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05335967
Enrollment
85
Registered
2022-04-20
Start date
2022-05-20
Completion date
2024-07-31
Last updated
2025-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Neoplasms, Self-Management

Keywords

Prostate cancer, Self-Management, Social participation, Resilience, Rear of cancer recurrence, Self-efficacy, Demoralization

Brief summary

Objectives: This project aims to develop a self-management program for survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy and determine its effectiveness. Methods: The investigators will develop a self-management program and conduct a study on survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy. And the investigators will test the effectiveness of the self-management program. After completing a pretest, participants will be randomly assigned to the experimental or control group. The self-management group will receive the self-management program for 12 weeks, whereas the information group will receive an information package on a healthy diet. Posttests will be administered 12 and 16 weeks after the pretest. The study variables will include physical symptoms and bothers, cancer-related self-efficacy, social participation, demoralization, and resilience.

Detailed description

Objectives: This project aims to develop a self-management program for survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy and determine its effectiveness. Methods: The investigators will develop a self-management program and conduct a study on survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy. And the investigators will test the effectiveness of the self-management program. After completing a pretest, participants will be randomly assigned to the experimental or control group. The self-management group will receive the self-management program for 12 weeks, whereas the information group will receive an information package on a healthy diet. The self-management program is included a self-management application, a self-management manual, and professional support. The information package consists of a manual on a healthy diet and a multimedia film on a healthy diet. Posttests will be administered 12 and 16 weeks after the pretest. The study variables will include physical symptoms and bothers, cancer-related self-efficacy, social participation, demoralization, and resilience. The statistical analyses will consist of independent sample t-tests, Chi-squire, and generalized estimating equation analysis.

Interventions

The self-management group will receive the self-management program for 12 weeks, including a self-management application, a self-management manual, and Professional support.

The patients in this group will receive an information package on a healthy diet.

Sponsors

Chang Gung Memorial Hospital
CollaboratorOTHER
National Science and Technology Council
CollaboratorFED
National Taipei University of Nursing and Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Prostate cancer survivors will include if they fit the following: * Received radical prostatectomy and suffering from urinary incontinence for at least one week * Eastern Cooperative Oncology Group 0-1 point, able to walk entirely independently * Have a smartphone or a tablet with a wireless network * Their intimate partner or one of the family members willing to learn together * Agreed to participate in the study and completed the informed consent form

Exclusion criteria

Prostate cancer survivors will be excluded if they had one or more of the following: * A request, with the consideration of family members, that the medical team not tell the patient about the diagnosis or condition of the disease * A history of psychiatric illness, such as dementia, depression; schizophrenia, or bipolar disorder * Suffer from other types of cancer and actively undergoing treatment

Design outcomes

Primary

MeasureTime frameDescription
Cancer related self-efficacyPre-testThe Mandarin version of the Cancer Survivors' Self-Efficacy Scale (CSSES) will be used to evaluate the cancer-specific self-efficacy of participants.The total score ranges from 11 to 110; the lower the score, the worse the self-efficacy.

Secondary

MeasureTime frameDescription
Urinary symptoms and bothersPre-testThe Mandarin version of the Expanded Prostate Cancer Index Composite (EPIC) will be used to measure the urinary symptoms and bother of the participants. Total 7 items and each question is linearly scaled from 0 (worst) to 100 (best).
Social participationPre-testA. The Mandarin version of the Older Adults Social Participation Scale will be used to assess participants' social participation. The scale includes 12 items with a score range of 12 to 60. A higher score shows a higher degree of social participation. B. Self-designed items will be used to assess participants' willingness to participate in social activities (1 item) and their satisfaction with social activities (1 item). Each item will have a score range of 0 to 10, with higher scores indicating a greater willingness to participate or higher satisfaction.
DemoralizationPre-testThe Mandarin version of the Demoralization Scale will be used to assess participants' demoralization. The scale includes 24 items, and the score range is 0-96. A higher score means higher demoralization.
ResiliencePre-testThe Mandarin version of the Connor-Davidson Resilience Scale will be used to measure the psychological resilience of participants. The scale has 10 items, and the score range is 0-100. A higher score reflects better resilience.

Other

MeasureTime frameDescription
Demographic characteristic and disease information list 1Pre-testAge
Demographic characteristic and disease information list 2Pre-testMarital status
Demographic characteristic and disease information list 3Pre-testEducation level
Demographic characteristic and disease information list 4Pre-testReligious beliefs
Demographic characteristic and disease information list 9Pre-testTreatment methods
Demographic characteristic and disease information list 6Pre-testCancer stage
Demographic characteristic and disease information list 7Pre-testChronic disease history
Satisfaction and evaluation of self-management intervention12 weeks after the pretestSelf-designed five items will be used to assess these outcomes.Each item is scaled from 0 (worst) to 100 (best).
Demographic characteristic and disease information list 5Pre-testEmployment status
Demographic characteristic and disease information list 10Pre-testLatest serum level of prostate-specific antigen (ng/mL)
Demographic characteristic and disease information list 1112 weeks after the pretestLatest serum level of prostate-specific antigen (ng/mL)
Demographic characteristic and disease information list 1216 weeks after the pretestLatest serum level of prostate-specific antigen (ng/mL)
Demographic characteristic and disease information list 8Pre-testTime of diagnosis (months)

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026